氧化状态,静脉血栓症患者的铁血水平
Salvatore Santo Signorelli1, Andrea Barbagallo1, Gea Oliveri Conti2
1Department of Clinical and Experimental Medicine, University of Catania, Via Santa Sofia 80, 95123 Catania, Italy.
Antioxidants (Basel, Switzerland)
|June 27, 2024
概括
氧化应激 (OxS) 和铁 (Fe) 失调与静脉血栓症 (VTE) 有关. 这项研究发现VTE患者的OxS标志物升高,Fe增加和肝素 (Hep) 升高,这表明它们在VTE发展中的作用.
科学领域:
- 生物化学 生化学
- 血液学 血液学 血液学
- 病理生理学 病理生理学
背景情况:
- 静脉血栓栓塞 (VTE) 是一个严重的健康问题.
- 氧化应激 (OxS) 越来越多地被认为是VTE的潜在危险因素.
- 铁 (Fe) 代谢,肝素 (Hep) 调节和OxS在VTE病变发生中的相互作用需要进一步阐明.
研究的目的:
- 为了研究氧化应激标志物,血铁含量和肝素蛋白水平在静脉血栓症患者之间的关联.
- 探索铁失调和氧化应激在VTE发展中的潜在作用.
主要方法:
- 对20名住院VTE患者和20名健康对照进行了病例对照研究.
- 氧化应激通过测量麦隆迪阿尔代海德 (MDA),4-氨酸 (4-HNE) 和超氧化脱酶 (SOD) 来评估.
- 两个组的血铁 (Fe) 和肝素 (Hep) 水平都得到量化.
主要成果:
- 与对照组相比,VTE患者的MDA和4-HNE水平显著更高,SOD活性较低,表明活性OxS.
- 血铁含量升高,肝素含量在静脉瘤患者中明显高于健康人群.
- 在VTE患者和对照人群之间,在所有测量参数中观察到统计学上显著的差异.
结论:
- 这些发现表明,活性氧化应激,铁的失调和肝素的过度生产与静脉血栓形成有关.
- 铁的失调似乎有助于氧化应激,可能促进炎症和VTE中的血栓前状态.
- 氧化应激和铁代谢,包括肝素调节,是VTE风险评估和管理的有希望的目标.
相关概念视频
Disorders of Hemostasis
831
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
831
Oxygen Transport in the Blood
2.6K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
2.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675


